IL-12 promotes T h 1 development/IFN-g expression by activating STAT4. However, it is still unclear how STAT4 elicits IFN-g promoter activation. Here, we investigated the mechanism by which IL-12-activated STAT4 functions for IFN-g induction in TCR-triggered T cells. TCR stimulation induced high levels of IFN-g production depending on co-stimulation with IL-12. IL-12 stimulation greatly enhanced the promoter-binding activity of c-Jun/AP-1, a critical transcription factor for IFN-g gene expression in wild-type T cells, but not in STAT4-de®cient (STAT4 ±/± ) T cells. Comparable amounts of c-Jun were induced by TCR stimulation in both wild-type and STAT4 ±/± T cells irrespective of IL-12 co-stimulation. However, c-Jun bound to STAT4 in IL-12-co-stimulated wild-type T cells. c-Jun forming a complex with STAT4 ef®ciently interacted with the AP-1-related sequence of the IFN-g promoter. Such an enhanced c-Jun binding did not occur in STAT4 ±/± T cells. These results show that STAT4 contributes to enhancing IFN-g expression by up-regulating the binding of TCR signal-induced AP-1 to the relevant promoter sequence.
Introduction
Upon antigen sensitization, naive CD4 T cells differentiate into two groups of polarized effector cells, T h 1 and T h 2. These two subsets of cells are de®ned by the pro®le of cytokines they produce (1) and this pro®le correlates with functional differences. Namely, T h 1 cells are characterized by the acquisition of the capacity to produce IFN-g capable of mediating antiin¯ammatory/infectious immune responses, whereas T h 2 cells secrete mainly IL-4 and function to induce humoral immune responses (2, 3) .
Considerable effort has been made to investigate the factors that determine differentiation of T h cells (4, 5) . Among these, the composition of the cytokines in the environment at the time of initial exposure to antigen is of crucial importance to the outcome of T h differentiation (6) . Ligation of the IL-4 receptor by IL-4 produced in the milieu drives a naive T h cell down a T h 2 differentiation through STAT6 activation, while IL-12 promotes IFN-g production and T h 1 development via signaling pathways that lead to STAT4 activation (7±9). Recent studies have shown that T-bet is critical for IFN-g expression and T h 1 lineage commitment (10) . Nevertheless, it is still possible that the IL-12/STAT4 signaling pathway is required to sustain high levels of IFN-g expression and ensure T h 1 development. Indeed, STAT4 functions for IFN-g expression in TCR/IL-12 (8, 9) and IL-12/IL-18 stimulation (11, 12) . However, it remains unclear how STAT4 functions for IFN-g gene expression, particularly in the former. This confusion could result from the fact that no apparent STAT4-binding sequence exists on the IFN-g promoter.
In the present study, we investigated how STAT4 acts as a transcription factor to enhance IFN-g expression in TCRtriggered T cells. The results show that TCR-triggered T cells produce large amounts of IFN-g depending on the presence of IL-12. AP-1 was previously shown to be induced by TCR stimulation and to function as a potent transcription factor for IFN-g gene expression (13) . Our results demonstrated that the enhanced binding of AP-1 to the IFN-g promoter sequence was achieved by its interaction with IL-12-activated STAT4. STAT4 ±/± T cells generated comparable amounts of AP-1 to those in wild-type T cells, but failed to up-regulate the AP-1 binding following IL-12 co-stimulation. These results provide a mechanistic explanation for the role of STAT4 in IFN-g expression in TCR-triggered T cells.
Methods

Mice
BALB/c mice were purchased from Shizuoka Laboratory Animal Center (Hamamatsu, Japan). STAT4-de®cient (STAT4 ±/± ) BALB/c mice (BALB/c-Stat4 tm1Gru ) (8) were obtained from Jackson Laboratories (Bar Harbor, ME) and bred in our laboratory.
Reagents
Mouse rIL-12 was provided by Genetics Institute (Cambridge, MA). Anti-CD3 (145-2C11) (14) , anti-CD28 (Pv-1) (15), anti-IL-12 (16) and anti-I-A d/b (34-5-3S) (17) mAb were puri®ed from culture supernatants or ascitic¯uids of respective hybridomas. Anti-c-Jun (H-79/sc-1694 and N/sc-45x), anti-c-Fos (4-10G/sc-413) and anti-STAT4 (C-20/sc-486 and L-18/sc-485x) antibodies as well as normal rabbit Ig were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Anti-phosphotyrosine mAb (4G10) and anti-phosphoserine-c-Jun (Ser 63) antibodies were from Upstate Biotechnology (Lake placid, NY) and New England Biolabs (Beverly, MA) respectively.
Preparation of T cell populations
Mouse lymph node cells were depleted of B cells and Ia + antigen-presenting cells by immunomagnetic negative selection as previously described (18) . The CD4 and CD8 T cell subsets were positively selected from puri®ed T cell populations (18) using superparamagnetic microbeads conjugated to anti-CD4 or anti-CD8 mAb (Miltenyi Biotec, Sunnyvale, CA).
Stimulation of T cells with anti-CD3 plus anti-CD28 mAb
Anti-CD3 (0.5 or 5 mg/ml) and anti-CD28 (2 mg/ml) were coimmobilized to 24-well culture plates (25820; Corning Glass Works, Corning, NY) in a volume of 0.5 ml. After 3 h, solutions were discarded and plates were washed with PBS twice. Puri®ed T cells were cultured in the presence or absence of 1000 pg/ml rIL-12 in 2 ml of RPMI 1640 medium supplemented with 10% FCS and 2-mercatoethanol at 1.5 Q 10 6 cells/well for various times in a CO 2 incubator.
Measurement of IFN-g concentrations
IFN-g concentrations were measured by mouse IFN-g ELISA (12) .
Preparation of total cell lysates/nuclear extracts and immunoprecipitation/immunoblotting
Total cell lysates were prepared by lysing cells in cell lysis buffer (1% Triton X-100, 150 mM NaCl, 10 mM Tris, pH 7.4, 1 mM EDTA, 1 mM EGTA, pH 8.0, 0.2 mM sodium orthovanadate, 0.2 mM PMSF and 0.5% NP-40). Nuclear extracts were prepared as follows. After washing with PBS, cells were resuspended in cell lysis buffer (20 mM HEPES±NaOH, pH 7.9, 20 mM NaF, 1 mM Na 3 VO 4 , 1 mM EDTA and 0.1 mM EGTA) supplemented with 0.2% NP-40, 1 mM dithiothreitol, 1 mg/ml aprotinin, 1 mg/ml leupeptin and 0.1 mM Pefabloc (Roche, Mannheim, Germany). The nuclei were pelleted and then extracted with vigorous agitation at 4°C in the above buffer without NP-40, but containing 0.42 M NaCl, 20% glycerol and protease inhibitors as described above. Immunoprecipitation and immunoblotting were performed as previously described (12) .
Electrophoretic mobility shift assay (EMSA)
EMSA was performed as previously described (12) . The AP-1 consensus oligonucleotide probe (5¢-CGCTTGATGACTCA-GCCGGAA-3¢) was purchased from Santa Cruz Biotechnology. The oligonucleotide probe corresponding to the AP-1-binding sequence present in the mouse IFN-g promoter (5¢-GCGGGGCTGTCTCATCGTCAGA-3¢) was prepared in our laboratory.
Oligonucleotide DNA precipitation
The procedure was essentially the same as that previously described (12) . Nuclear extracts were incubated with agarose beads coupled to an AP-1 consensus oligonucleotide (TGACTCA) (Santa Cruz Biotechnology). The binding reaction was performed for 45 min at 4°C in a binding buffer. The agarose beads were washed 5 times with binding buffer. The bound proteins were released with SDS loading buffer, separated by 10% SDS±PAGE, transferred to PVDF membrane and visualized with the relevant antibodies.
RT-PCR
The following oligonucleotides were used: IL-12Rb1 sense primer 5¢-CAAGCACAGGAACCACACA-3¢, IL-12Rb1 antisense primer 5¢-CAGAGACGCGAAAATGATG-3¢, IL-12Rb2 sense primer 5¢-AATTCAGTACCGACGCTCTCA-3¢, IL-12Rb2 anti-sense primer 5¢-ATCAGGGGCTCAGGCTCTTCA-3¢, bactin sense primer 5¢-AGAAGAGCTATGAGCTGCCTGACG-3¢ and b-actin anti-sense primer 5¢-CTTCTGCATCCTGTCA-GCAATGCC-3¢. Cycle parameters were: annealing 1 min at 60°C (IL-12Rb1 and b2) or 55°C (b-actin), elongation 1 min at 72°C and denaturation 0.5 min at 94°C. Resulting PCR products were separated in 1% agarose gel and visualized by SYBR Green staining. Sequences of the IL-12Rb1, IL12Rb2 and b-actin (for standardization) were ampli®ed out of 
Results
Requirement of IL-12 and STAT4 for TCR-stimulated IFN-g production
Wild-type and STAT4 ±/± T cells were stimulated with a low (0.5 mg/ml) or high (5.0 mg/ml) dose of immobilized anti-CD3 plus anti-CD28 mAb in the presence or absence of rIL-12. IFN-g production by wild-type T cells stimulated with a low dose of anti-CD3 was markedly enhanced by co-stimulation with IL-12, while such an IL-12-mediated up-regulation did not occur in STAT4 ±/± T cells (Fig. 1A) . Unlike stimulation with a low dose of anti-CD3, wild-type T cells stimulated with a high dose of anti-CD3 produced relatively large amounts of IFN-g even in the absence of IL-12 ( Fig. 1B, left) . Under this condition, IFN-g production by STAT4 ±/± T cells was weak irrespective of IL-12 co-stimulation (Fig. 1B, right) . By positively selecting CD4 + and CD8 + T cells, we examined their responsiveness to TCR/ IL-12 stimulation (Fig. 2) . The patterns of IFN-g production by either the CD4 + or CD8 + T cell subset were similar to those observed for unfractionated T cells in terms of IL-12-mediated enhancement only in wild-type T cells.
IL-12R, particularly an IL-12Rb2 subunit, is induced following stimulation of resting T cells with anti-CD3 plus anti-CD28 (18±20). To exclude the possibility that the failure of IL-12 to up-regulate IFN-g production in STAT4 ±/± T cells is primarily due to their inability to induce a functional IL-12R complex, the induction of IL-12b1 and b2 was compared between wild-type and STAT4 ±/± T cells stimulated with anti-CD3/anti-CD28 in the presence or absence of IL-12. As shown in Fig. 3 , there was no substantial difference between wild-type and STAT4 ±/± T cells in the levels of IL-12Rb1 and b2 mRNA.
IL-12-independent STAT4 phosphorylation in T cells stimulated with a high dose of anti-CD3/anti-CD28
Figure 4(A) shows that stimulation of wild-type T cells with a high dose of anti-CD3 alone or together with anti-CD28 induced moderate levels of IFN-g production even without IL-12 co-stimulation. Because this was not the case for STAT4 ±/± T cells, it is possible that this differential IL-12-independent IFNg production is also generated depending on STAT4 signaling. To determine this, we examined STAT4 phosphorylation in wild-type T cells stimulated with anti-CD3/anti-CD28 without IL-12 co-stimulation. Unlike IL-12-stimulated STAT4 activation (19, 20) , STAT4 phosphorylation was not observed shortly after stimulation with anti-CD3 plus anti-CD28 (data not shown). However, STAT4 was phosphorylated 12 h after the stimulation and the levels were slightly increased up to 36 h after the stimulation (Fig. 4B ). Figure 4 (C) shows that STAT4 phosphorylation is inducible irrespective of CD28 co-stimulation or is only slightly detected depending on CD28 co-stimulation in T cells stimulated with a high or low dose of anti-CD3 respectively. Because signi®cant amounts of IFN-g are produced by STAT4 ±/± T cells (Fig. 4A ), STAT4 is not necessarily an absolute requirement for IFN-g production. However, enhanced levels of IFN-g expression by TCR-triggered T cells associates with the involvement of STAT4 function.
STAT4 is required to up-regulate the binding of AP-1 to the IFN-g promoter sequence AP-1 is induced by TCR stimulation and by forming complexes with other transcription factors; this transcription factor interacts with the NF-AT/AP-1 site (21) and CD28-responsive element (22) of the IL-2 gene promoter. An earlier study (13) showed that the AP-1-binding site exists on the IFN-g gene promoter and that the binding activity of TCR signal-induced AP-1 is enhanced by co-stimulation with IL-12. We examined AP-1-binding activity generated in TCR/IL-12-stimulated T cells (Fig. 5) . While AP-1-binding activity was detectable in T cells stimulated with a low dose (0.5 mg/ml) of anti-CD3 plus anti-CD28, the binding of AP-1 was markedly enhanced by IL-12 co-stimulation.
Using wild-type and STAT4 ±/± T cells, we examined whether STAT4 is involved in IL-12-mediated up-regulation of AP-1 binding. As shown in Fig. 6 , concurrent stimulation with IL-12 again up-regulated AP-1-binding activity in wild-type T cells. However, such an up-regulation was not induced in STAT4 ±/± T cells. This was the case in EMSA using oligonucleotide probes for either the consensus AP-1-binding sequence (Fig. 6, upper  panel) or the AP-1-binding sequence present in the mouse IFN-g promoter (Fig. 6, lower panel) . Thus, STAT4 is required to up-regulate the binding of TCR signal-induced AP-1 to the relevant promoter sequence.
STAT4 de®ciency does not affect the induction of c-Jun/AP-1 by TCR stimulation
To determine whether STAT4 de®ciency in¯uences the induction of AP-1, we examined the amounts of c-Jun as a major component of AP-1. Total cell lysates and nuclear extracts were prepared from wild-type and STAT4 ±/± T cells stimulated with anti-CD3/anti-CD28 in the presence or absence of IL-12. Total cell lysates were immunoblotted with anti-c-Jun or anti-STAT4 (Fig. 7A) . Nuclear extracts were blotted with antiphosphoserine c-Jun antibody and then reblotted with anti-cJun antibody (Fig. 7B) . The results show that the amounts of cJun induced in the total cell (Fig. 7A) or nuclear (Fig. 7B ) fraction following TCR stimulation were comparable between wild-type and STAT4 ±/± T cells, and did not differ between the presence and absence of IL-12 signals. There was no substantial difference in serine phosphorylation of c-Jun recruiting into the nuclear fraction (Fig. 7B, upper) . The results also show that no essential difference in cellular and nuclear amounts of another AP-1 component, c-Fos, was seen between wild-type and STAT4 ±/± T cells. Thus, while STAT4 ±/± T cells exhibit a markedly reduced level of AP-1-binding activity (Fig. 6 ), these T cells can induce comparable amounts of c-Jun/AP-1 to those in wild-type T cells.
STAT4 interacts with c-Jun to form a complex
Our recent study (12) demonstrated that IL-12 and IL-18 activate STAT4 and c-Jun/AP-1 respectively, and that the binding activity of c-Jun/AP-1 is up-regulated through its interaction with STAT4, providing a mechanism of IL-12/IL-18 synergy for IFN-g promoter activation. Therefore, we examined whether such a complex is also formed following TCR/IL-12 stimulation (Fig. 7C) . Nuclear extracts from TCR-or TCR/IL-12-stimulated T cells were immunoprecipitated with anti-c-Jun. Anti-c-Jun immunoprecipitates were blotted with anti-STAT4. Portions of nuclear extracts were examined for the amount of STAT4 and the level of its tyrosine phosphorylation. Enhanced amounts of phosphorylated STAT4 were found in IL-12-costimulated wild-type T cells (Fig. 7C, middle and bottom  panels) . Notably, anti-c-Jun immunoprecipitate of this nuclear extract contained STAT4 (Fig. 7C, upper panel) . Thus, these results indicate that c-Jun induced by TCR stimulation interacts with STAT4 recruited after IL-12 stimulation, producing a complex with STAT4.
c-Jun interacting with STAT4 ef®ciently binds to the AP-1-binding sequence
To examine whether a complex of c-Jun and STAT4 ef®ciently binds to the AP-1-binding sequence, we took advantage of oligonucleotide DNA precipitation (12) . Nuclear extracts from TCR or TCR/IL-12-stimulated wild-type and STAT4 ±/± T cells were allowed to interact with agarose beads coupled to the AP-1-binding oligonucleotide sequence. The bound proteins were analyzed for c-Jun and STAT4 by immunoblotting using relevant antibodies (Fig. 8) . A much larger amount of c-Jun bound to the AP-1 sequence in the nuclear extracts from IL-12-co-stimulated than IL-12-non-co-stimulated wild-type T cells. c-Jun from the former group was found to be serine phosphorylated. Importantly, a large amount of STAT4 was recovered after AP-1 oligonucleotide precipitation, which is consistent with the observation that c-Jun interacts with STAT4 (Fig. 7C) . In the de®ciency of STAT4, the binding of c-Jun to the AP-1 sequence was not enhanced in the TCR/IL-12-costimulated group. Taken together, these results indicate that STAT4 interacts with c-Jun and thereby facilitates c-Jun binding to the AP-1 sequence.
Discussion
While not all IFN-g production appears to depend on STAT4 (23, 24) , IL-12 stimulation and STAT4 activation contribute to the development of IFN-g-producing T h 1 cells. However, the speci®c transcriptional target of STAT4 involved in IFN-g gene expression after TCR triggering remains unclear. The present study showed that T cells triggered with low magnitudes of TCR stimuli produce large amounts of IFN-g depending on IL-12 stimulation and STAT4 involvement. While TCR stimulation leads to the generation of a potent transcription factor, AP-1, for IFN-g promoter activation, IL-12 and STAT4 were required to induce high levels of AP-1 binding to the relevant IFN-g promoter sequence. The results further demonstrated that Recent studies have demonstrated that T-bet is a potent transactivator of the IFN-g gene and functions as the master regulator of T h 1 lineage commitment (10) . Because IFN-g is a potent inducer of T bet expression in TCR-triggered T cells (25, 26) , T-bet and IFN-g expression forms a positive feedback loop. As TCR-triggered T cells can express IFN-g in the absence of STAT4 signaling, STAT4 is not necessarily essential for T-bet induction (26, 27) . While IFN-g and T-bet expression occur independently of IL-12/STAT4 signaling, IFN-gstimulated T-bet expression was recently shown to induce IL12Rb2 expression that is a requirement of T h 1 development (26) . Here, we observed that detectable, albeit small, amounts of IFN-g were produced by both wild-type and STAT4 ±/± T cells stimulated with anti-CD3 (0.5 mg/ml) plus anti-CD28 without IL-12 stimulation. Consistent with this, comparable levels of IL12Rb1 and b2 mRNA expression were induced in both types of T cells after anti-CD3/anti-CD28 stimulation. However, IFN-g production was greatly up-regulated only in wild-type T cells when they were co-stimulated with IL-12 and such an upregulation was not observed in STAT4 ±/± T cells. Thus, STAT4 is required to enhance/prolong IFN-g expression in developing T cells. The following scenario (28) may be feasible. TCR triggering induces IFN-g production required for T-bet expression. T-bet induction does not necessarily require IL-12/STAT4 signaling. T-bet functions to induce IL-12R expression. Stimulation of these developing T cells with IL-12 markedly augments T h 1 development and IFN-g production in a STAT4-dependent way.
TCR signaling is regarded as the typical physiologic stimulus for IFN-g induction. However, IL-12 and IL-18 induce IFN-g production in a TCR-independent manner (29, 30) , and exhibit a striking synergy when they act in a combination (11, 12, 31) . Two different mechanisms of synergy have been reported. First, IL-12 up-regulates IL-18R expression (11, 32) . Second, IL-12 and IL-18 activate different transcription factors: the former activates STAT4, and the latter NF-kB (31) and AP-1 (13) . Our recent study (12) showed that STAT4 contributes to IFN-g promoter activation by interacting with cJun/AP-1 and up-regulating its binding to the AP-1-relevant sequence. AP-1 is a more potent transcription factor for IFN-g promoter activation than STAT4 (13) . However, the induction of high AP-1 binding required the interaction of AP-1 with STAT4 (12) . Additionally, our study (12) gave the following observations. (i) There is no apparent STAT4-binding sequence on the mouse IFN-g promoter. In fact, STAT4 did not bind to the promoter fragment (positions ±436 to +113) for which the IL-12/IL-18 transcriptional synergy was observed (12) . This represented a new mechanism of synergistic promoter activation in which a transcription factor acts without directly binding to the promoter sequence. (ii) Unlike AP-1 binding, the binding activity of NF-kB was not up-regulated in the presence of STAT4 (12) . Thus, IL-12 signals functioned to selectively enhance AP-1 binding.
According to previous studies (12, 13) , how binding of AP-1 to the relevant IFN-g promoter sequence is up-regulated is key for enhanced IFN-g promoter activation. As TCR signaling generates AP-1, the present study aimed to investigate whether the up-regulation of AP-1-binding activity through the STAT4/AP-1 interaction also occurs during TCR/IL-12 costimulation. To focus on the role for STAT4, the induction of AP-1-binding activity was compared between wild-type and STAT4 ±/± T cells. High AP-1-binding activity was induced only in wild-type T cells depending on the interaction of c-Jun/ AP-1 with STAT4. There was no substantial difference in c-Jun induction between wild-type and STAT4 ±/± T cells as well as between the presence and absence of IL-12 signals. In TCR stimulation alone, low levels of c-Jun/AP-1 binding were observed in EMSA and oligonucleotide DNA precipitation, and the levels were comparable between wild-type and STAT4 ±/± T cells. In TCR/IL-12 co-stimulation, c-Jun/AP-1 induced in wild-type T cells exhibited enhanced binding to the AP-1-binding sequence by interacting with STAT4, whereas c-Jun/AP-1 generated in STAT4 ±/± T cells did not. Thus, these results indicate that STAT4 is critical for upregulating the binding of AP-1 to the relevant IFN-g promoter sequence (Fig. 9) .
While IFN-g production is up-regulated by the IL-12-STAT4 signaling pathway, it is also obvious that moderate amounts of IFN-g are produced without IL-12 stimulation so far as T cells are given high magnitudes of TCR stimuli (5 mg/ml anti-CD3). In this context, our present results showed that stimulation of wild-type T cells with a high dose of anti-CD3 plus anti-CD28 results in detectable, albeit low, levels of STAT4 phosphorylation in the absence of exogenous IL-12. It is unlikely that STAT4 activation was induced by endogenously produced IL-12 because antigen-presenting cells had been depleted of a responding population and, moreover, cultures included suf®cient amounts of anti-IL-12 mAb to neutralize endogenous IL-12 that may be produced by residual antigen-presenting cells, if any. Although the mechanism of IL-12-independent STAT4 phosphorylation is unknown, the following postulation may be feasible. A recent study (33) showed that lipid rafts enriched in cytokine receptors and associated signaling molecules provide an ef®cient place for cytokine signaling. Therefore, condensation of raft-associated cytokine receptors due to potent raft aggregation may lead to the activation of cytokine receptor-associated signaling molecules that usually occurs as a result of ligand binding. Anti-CD3/anti-CD28 costimulation induces aggregation of TCR and lipid rafts (34). Further studies will be required to directly investigate the mechanism of an IL-12-independent STAT4 phosphorylation.
Regarding an IL-12-independent mechanism, an earlier study (24) showed that CD4 + T cells require IL-12 and STAT4 activation for IFN-g induction, whereas CD8 + T cells can produce IFN-g independently of IL-12. However, IL-12 and STAT4 requirements in IFN-g induction were compared between CD4 + and CD8 + T cells stimulated with a high dose of anti-CD3 (10 mg/ml) plus anti-CD28 followed by re-stimulation with anti-CD3 (24) . In contrast, our results showed that like CD4 + T cells, CD8 + T cells in a primary culture require IL-12 stimulation and STAT4 activation for IFN-g induction. Our observations also contrast with the differential requirement of T-bet induction for IFN-g expression by CD4 + versus CD8 + T cells (35) .
Although an additional pathway for IL-12/STAT4-independent IFN-g production exists (23) , it is evident that IL-12 stimulation and STAT4 activation is required for IFN-g gene expression by T cells triggered with low magnitudes of TCR stimuli. Our present results illustrate a role for STAT4 in mounting a high binding activity of AP-1 that is induced by TCR stimulation. These results are consistent with the observation (12) that under synergistic IFN-g production of IL-12 and IL-18, IL-12-induced STAT4 contributes to IFN-g expression by up-regulating the binding activity of IL-18-induced AP-1 via the formation of the STAT4±c-Jun/AP-1 complex. The present results could also contribute to a better understanding of STAT4-mediated T h 1 differentiation in terms of the acquisition of the capacity to promote IFN-g expression in TCR-triggered T cells.
